September 18, 2023

A Novel Way to Treat Adults With Moderate-To-Severe Plaque Psoriasis – A BMS-sponsored episode

Despite the availability of many treatment options for moderate-to-severe plaque psoriasis, there is still a need for additional therapies. Hear from Ryan Moslin, Principal Scientist, BMS, who suffers from moderate-to-severe plaque psoriasis, and Tom Scharnitz, M.D., the Senior Director and US Medical Lead for Dermatology, BMS, as they provide the science and research behind an oral treatment for moderate-to-severe plaque psoriasis.

Please see Important Safety Information and U.S. Full Prescribing Information including Medication Guide for SOTYKTU, indicated for the treatment of moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy.

This PsoundBytes™ episode is sponsored by Bristol-Myers Squibb.

Related Items

Stay in the Know

Expert tips, can’t-miss events, and the latest news, straight to your inbox.

National Health Council Standards of ExcellenceCharity NavigatorCommunity Health Charities logo

Copyright © 1996-2023 National Psoriasis Foundation/USA

Duplication, rebroadcast, republication, or other use of content appearing on this website is prohibited without written permission of the National Psoriasis Foundation (NPF).

NPF does not endorse or accept any responsibility for the content of external websites.

NPF does not endorse any specific treatments or medications for psoriasis and psoriatic arthritis.

We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.